Transcription of Public Assessment Report Repeat-Use Mutual Recognition ...
{{id}} {{{paragraph}}}
Example: barber
Public Assessment Report Repeat-Use Mutual Recognition ...
PAR SolarazeTM 3% Gel UK/H/0226/001/E022. Public Assessment Report Repeat-Use Mutual Recognition Procedure SolarazeTM 3% Gel UK/H/0226/002/E02. UK licence no: PL 16973/0012. Almirall, 1. PAR SolarazeTM 3% Gel UK/H/0226/001/E022. LAY SUMMARY. This Repeat-Use Mutual Recognition Procedure (UK/H/0226/001/E02) granted a Marketing Authorisation to Almirall SA for the medicinal product Solaraze 3% Gel (PL 16973/0012) in Greece, Spain and Poland; the procedure concluded positively on 18th November 2010. A. national licence for Solaraze 3% Gel was initially granted in the UK on 25th July 1997.
PAR SolarazeTM 3% Gel UK/H/0226/001/E022 4 Module 1 Product Name Solaraze™ 3%, gel Type of Application Hybrid, Article 10.3 Active Substance Diclofenac sodium Form Gel Strength
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: